Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is
- To evaluate the efficacy of PRC-4016 by assessment of the percentage change in blood
lipids and lipoprotein parameter from baseline after 12 weeks of treatment
- To evaluate the safety of PRC-4016 as assessed by adverse events and other safety
parameters